CNPAX
Price
$73.30
Change
+$0.37 (+0.51%)
Updated
Dec 3 closing price
Net Assets
162.64B
MGFNX
Price
$10.18
Change
+$0.04 (+0.39%)
Updated
Dec 3 closing price
Net Assets
153.58M
Interact to see
Advertisement

CNPAX vs MGFNX

Header iconCNPAX vs MGFNX Comparison
Open Charts CNPAX vs MGFNXBanner chart's image
American Funds New Perspective 529A
Price$73.30
Change+$0.37 (+0.51%)
VolumeN/A
Net Assets162.64B
MassMutual Global R3
Price$10.18
Change+$0.04 (+0.39%)
VolumeN/A
Net Assets153.58M
CNPAX vs MGFNX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MGFNX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and MGFNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. MGFNX (154M). CNPAX pays higher dividends than MGFNX: CNPAX (0.46) vs MGFNX (0.00). CNPAX was incepted earlier than MGFNX: CNPAX (24 years) vs MGFNX (21 years). MGFNX (1.63) is less costly to investors than CNPAX (0.77). CNPAX is a more actively managed with annual turnover of: 24.00 vs. MGFNX (6.00). MGFNX has a lower initial minimum investment than CNPAX: MGFNX (0) vs CNPAX (250). CNPAX annual gain was more profitable for investors over the last year : 11.48 vs. MGFNX (-3.26). CNPAX return over 5 years is better than : 25.45 vs. MGFNX (-39.70).
CNPAXMGFNXCNPAX / MGFNX
Total Expense Ratio0.771.6347%
Annual Report Gross Expense Ratio0.771.6347%
Fund Existence24 years21 years-
Gain YTD19.15513.867138%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets163B154M105,844%
Annual Yield % from dividends0.460.00-
Returns for 1 year11.48-3.26-353%
Returns for 3 years44.94-16.11-279%
Returns for 5 years25.45-39.70-64%
Returns for 10 years100.39-30.53-329%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMSCX26.21N/A
N/A
Invesco Main Street All Cap C
SHPCX15.11N/A
N/A
Saratoga Health & Biotechnology C
LAFTX21.25N/A
N/A
Lord Abbett Affiliated R5
GMXPX25.96N/A
N/A
Goldman Sachs Large Cp Val Insghts P
WPGSX11.85N/A
N/A
WPG Partners Select Small Cap Value Ins